Cadian Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-627,203	Closed	-$26M	–	36
2022 Q3	$26M	Sell	627,203 -151,355	-19%	-$6.27M	1.52%	19
2022 Q2	$46.4M	Buy	+778,558	New	+$46.4M	3.14%	12